Cargando…
A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer death that typically presents at an advanced stage. No reliable markers for early detection presently exist. The prominent tumor stroma represents a source of circulating biomarkers for use together with cancer cell-derived biomarker...
Autores principales: | Mason, James, Lundberg, Erik, Jonsson, Pär, Nyström, Hanna, Franklin, Oskar, Lundin, Christina, Naredi, Peter, Antti, Henrik, Sund, Malin, Öhlund, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653916/ https://www.ncbi.nlm.nih.gov/pubmed/36361759 http://dx.doi.org/10.3390/ijms232112969 |
Ejemplares similares
-
Plasma Micro-RNA Alterations Appear Late in Pancreatic Cancer
por: Franklin, Oskar, et al.
Publicado: (2018) -
Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples
por: Borgmästars, Emmy, et al.
Publicado: (2021) -
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
por: Öhlund, Daniel, et al.
Publicado: (2013) -
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
por: Öhlund, D, et al.
Publicado: (2009) -
Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement
por: Nyström, Hanna, et al.
Publicado: (2015)